LL-37-induced caspase-independent apoptosis is associated with plasma membrane permeabilization in human osteoblast-like cells

Peptides. 2021 Jan:135:170432. doi: 10.1016/j.peptides.2020.170432. Epub 2020 Oct 28.

Abstract

The host defense peptide LL-37 is active against both gram-positive and gram-negative bacteria, but it has also been shown to reduce human host cell viability. However, the mechanisms behind LL-37-induced human host cell cytotoxicity are not yet fully understood. Here, we assess if LL-37-evoked attenuation of human osteoblast-like MG63 cell viability is associated with apoptosis, and if the underlying mechanism may involve LL-37-induced plasma membrane permeabilization. MG63 cell viability and plasma membrane permeabilization were investigated by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method and by measuring lactate dehydrogenase (LDH) release, respectively. Apoptosis was assessed by the terminal deoxynucleotidyl dUTP nick end labeling (TUNEL) assay and Annexin V flow cytometry, and caspase-3 and poly (ADP-ribose) polymerase (PARP) cleavage were determined by Western blot. LL-37 (4 and 10 μM) reduced both cell number and cell viability, and these effects were associated with a pro-apoptotic effect demonstrated by positive TUNEL staining and Annexin V flow cytometry. LL-37-induced apoptosis was not coupled to either caspase-3 or PARP cleavage, suggesting that LL-37 causes caspase-independent apoptosis in MG63 cells. Both LL-37 and the well-known plasma membrane permeabilizer Triton X-100 reduced cell viability and stimulated LDH release. Triton X-100-treated cells showed positive TUNEL staining, and the detergent accumulated cells in late apoptosis/necrosis. Similar to LL-37, Triton X-100 caused no PARP cleavage. We conclude that LL-37 promotes caspase-independent apoptosis, and that this effect seems coupled to plasma membrane permeabilization in human MG63 cells.

Keywords: Antimicrobial peptides (AMP); Apoptosis; Cathelicidin; Cytotoxicity; Innate immunity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimicrobial Cationic Peptides / genetics*
  • Antimicrobial Cationic Peptides / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / genetics*
  • Caspases / genetics*
  • Cathelicidins
  • Cell Membrane / genetics*
  • Cell Membrane Permeability / drug effects
  • Cell Membrane Permeability / genetics
  • Humans
  • Osteoblasts / metabolism

Substances

  • Antimicrobial Cationic Peptides
  • Caspases
  • Cathelicidins